BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 3488296)

  • 41. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
    Wagner JL; Hugli TE
    Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of complement-derived anaphylatoxins in normal human donor corneas.
    Mondino BJ; Sumner HL
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1945-9. PubMed ID: 2210989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma histamine but not anaphylatoxin levels correlate with generalized urticaria from infusions of anti-lymphocyte monoclonal antibodies.
    Dykewicz MS; Rosen ST; O'Connell MM; Patterson R; Kuzel TM; Gilyon KA
    J Lab Clin Med; 1992 Aug; 120(2):290-6. PubMed ID: 1500827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C4a: An Anaphylatoxin in Name Only.
    Barnum SR
    J Innate Immun; 2015; 7(4):333-9. PubMed ID: 25659340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low mature TGF-beta 2 levels in aqueous humor during uveitis.
    de Boer JH; Limpens J; Orengo-Nania S; de Jong PT; La Heij E; Kijlstra A
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3702-10. PubMed ID: 7522227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between aqueous humor protein level and outflow facility in patients with uveitis.
    Ladas JG; Yu F; Loo R; Davis JL; Coleman AL; Levinson RD; Holland GN
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2584-8. PubMed ID: 11581203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of complement activation by high-dose corticosteroids in total hip arthroplasty.
    Gammer W; Bengtson A; Heideman M
    Clin Orthop Relat Res; 1988 Nov; (236):205-9. PubMed ID: 3263243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
    Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
    Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of complement in atopic dermatitis.
    Kapp A; Schöpf E
    Acta Derm Venereol Suppl (Stockh); 1985; 114():152-4. PubMed ID: 3923750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Purification and functional assessment of C3a, C4a and C5a of the common carp (Cyprinus carpio) complement.
    Kato Y; Nakao M; Shimizu M; Wariishi H; Yano T
    Dev Comp Immunol; 2004 Jul; 28(9):901-10. PubMed ID: 15183031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C5a: a mediator of chemotaxis and cellular release reactions.
    Gerard C; Hugli TE
    Kroc Found Ser; 1981; 14():147-60. PubMed ID: 6975805
    [No Abstract]   [Full Text] [Related]  

  • 58. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S; Glovsky MM
    J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM; Breillatt J; Lazarus JM; Port FK
    N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaphylatoxins in preterm and term labor.
    Soto E; Romero R; Richani K; Espinoza J; Nien JK; Chaiworapongsa T; Santolaya-Forgas J; Edwin SS; Mazor M
    J Perinat Med; 2005; 33(4):306-13. PubMed ID: 16207115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.